• liver
  • Initial laboratory data was notable for hemoglobin 6.8 mg/dL, albumin 2.9 g/dL, platelets 76 x 10 3 /┬ÁL, creatinine 0.4 mg/dL, international normalized ratio 1.22, and an unremarkable liver panel aside from a chronically elevated alkaline phosphatase 249 U/L. The patient was started on intravenous pantoprazole and famotidine twice daily. (gi.org)
  • No liver biopsy was performed as the patient was already on prednisone for treatment of mastocytosis and was high risk for bleeding given worsening thrombocytopenia. (gi.org)
  • There is no consensus about the optimal treatment of hepatocellular carcinoma (HCC) with cirrhotic portal hypertension, While this group of patients are classified as hepatectomy contraindication according to guidelines from National Comprehensive Cancer Network (NCCN) and American Association for the Study of Liver Diseases (AASLD). (clinicaltrials.gov)
  • treatment
  • The investigators project is a prospective randomized controlled trial, planning to compare the safety, efficacy and quality of life between precise hepatectomy and combined interventional treatment on hepatocellular carcinoma (HCC) with cirrhotic portal hypertension, to make a further understanding of optimal strategy. (clinicaltrials.gov)